117 related articles for article (PubMed ID: 16309798)
1. [Pentoxifylline: a cheap substitute for anti-TNFalpha agents?].
Koenig M; Cathébras P; Guy C; Rousset H
Rev Med Interne; 2006 May; 27(5):400-5. PubMed ID: 16309798
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline: a drug with wide spectrum applications in dermatology.
Zargari O
Dermatol Online J; 2008 Nov; 14(11):2. PubMed ID: 19094840
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
Chen YM; Lin SL; Chiang WC; Wu KD; Tsai TJ
Kidney Int; 2006 Apr; 69(8):1410-5. PubMed ID: 16541021
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
5. The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial.
Ghorbani A; Omidvar B; Beladi-Mousavi SS; Lak E; Vaziri S
Nefrologia; 2012; 32(6):790-6. PubMed ID: 23169362
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
de Moura FJ; Leal PP; de Souza Furtado R; Muniz-Junqueira MI; Veiga JP
Toxicology; 2008 Jan; 243(1-2):66-74. PubMed ID: 18022309
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline inhibits human T-cell adhesion to dermal endothelial cells.
Bruynzeel I; van der Raaij LM; Willemze R; Stoof TJ
Arch Dermatol Res; 1997 Mar; 289(4):189-93. PubMed ID: 9143734
[TBL] [Abstract][Full Text] [Related]
8. Effects of pentoxifylline on the cytokines that may play a role in rejection and resistive index in renal transplant recipients.
Demir E; Paydas S; Balal M; Kurt C; Sertdemir Y; Erken U
Transplant Proc; 2006 Nov; 38(9):2883-6. PubMed ID: 17112855
[TBL] [Abstract][Full Text] [Related]
9. The renoprotective potential of pentoxifylline in chronic kidney disease.
Lin SL; Chiang WC; Chen YM; Lai CF; Tsai TJ; Hsieh BS
J Chin Med Assoc; 2005 Mar; 68(3):99-105. PubMed ID: 15813241
[TBL] [Abstract][Full Text] [Related]
10. [The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report].
Diallo BD; Diot B; Flament T; Plantier L; Diot P; Sow OY; Marchand-Adam S
Rev Pneumol Clin; 2018 Feb; 74(1):48-51. PubMed ID: 29122398
[TBL] [Abstract][Full Text] [Related]
11. Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia.
Coimbra R; Porcides RD; Melbostad H; Loomis W; Tobar M; Hoyt DB; Wolf P
Surg Infect (Larchmt); 2005; 6(1):73-85. PubMed ID: 15865553
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial.
Sidhu SS; Goyal O; Singla M; Bhatia KL; Chhina RS; Sood A
J Assoc Physicians India; 2012 May; 60():20-2. PubMed ID: 23029716
[TBL] [Abstract][Full Text] [Related]
13. The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study.
el-Darouti M; Marzouk S; Abdel Hay R; el-Tawdy A; Fawzy M; Leheta T; Gammaz H; Al Gendy N
Br J Dermatol; 2009 Aug; 161(2):313-9. PubMed ID: 19466963
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Bolignano D; D'Arrigo G; Pisano A; Coppolino G
PLoS One; 2015; 10(8):e0134104. PubMed ID: 26237421
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline: brief review and rationale for its possible use in the treatment of autism.
Gupta S; Rimland B; Shilling PD
J Child Neurol; 1996 Nov; 11(6):501-4. PubMed ID: 9120235
[No Abstract] [Full Text] [Related]
17. Pentoxifylline for Diabetic Nephropathy: an Important Opportunity to Re-purpose an Old Drug?
Bhanot S; Leehey DJ
Curr Hypertens Rep; 2016 Jan; 18(1):8. PubMed ID: 26747265
[TBL] [Abstract][Full Text] [Related]
18. Immunological mechanisms of pentoxifylline in chronic heart failure.
Shaw SM; Shah MK; Williams SG; Fildes JE
Eur J Heart Fail; 2009 Feb; 11(2):113-8. PubMed ID: 19168508
[TBL] [Abstract][Full Text] [Related]
19. A single prophylactic dose of pentoxifylline reduces high dependency unit time in cardiac surgery - a prospective randomized and controlled study.
Heinze H; Rosemann C; Weber C; Heinrichs G; Bahlmann L; Misfeld M; Heringlake M; Eichler W
Eur J Cardiothorac Surg; 2007 Jul; 32(1):83-9. PubMed ID: 17499999
[TBL] [Abstract][Full Text] [Related]
20. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
